CCRB Logo

Trial History Detail on 2005-09-08

CUHK_CCT00041

2005-09-08

Retrospective

Department of Ophthalmology & Visual Sciences, the Chinese University of Hong Kong

Nil

Nil

CHAN Wai Man

27623168

telephone

CHAN Wai Man

27623168

telephone

A study on the safety and effectiveness of photodynamic therapy with verteporfin in treating chronic focal or diffuse idiopathic central serous chorioretinopathy

Yes

2003-05-01

Eye Diseases

Procedure

photodynamic therapy

24 months

observation

Inclusion criteria: Be aged 18 years or older VA with Snellen equivalent </= 20/30 but „d 20/200 Fluorescein angiographic patterns of either Leakage area either in the subfoveal or juxtafoveal area Area of CNV „d 50% of the area of the total lesion Greatest linear dimension of the entire lesion must not exceed 5400 £gm Exclusion criteria: on exogenous corticosteroid systemic diseases such as Cushing¡¦s disease or renal diseases of glomerulonephritis pregnancy visual acuity worse than 20/200 in the affected eye myopia </= -6.00 diopters or other maculopathy tear (rip) of the retinal pigment epithelium a history of laser photocoagulation ocular surgery in the recent 3 months any contraindication for the verteporfin infusion or fluorescein injection

Randomized

Placebo

Open label

Single group

2005-08-31

20

Recruiting

Visual acuity

duration of subretinal fluid

No

2013-01-16


Yes

Type Access Document Published On  
No documents yet.
  • Page 1 of 1.